Smoking-cessation support for people getting lung cancer screening at MedStar Health
Providing Tobacco Treatment to Patients Undergoing Lung Cancer Screening at MedStar Health: A Randomized Trial
This project compares two ways to help people who smoke quit when they come for lung cancer screening.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Georgetown University NIH-funded |
| Lab location | 1 site (Washington, United States) |
| Project ID | NIH-11306567 on NIH RePORTER |
What this research studies
If you smoke and are scheduled for lung cancer screening at MedStar Health, this project will offer one of two evidence-based smoking-cessation programs and randomly assign which one you receive. The trial uses real-world procedures at ten MedStar lung screening sites and adds practical strategies to improve reach and engagement, especially for racial and ethnic minorities, underinsured patients, and people not ready to quit. All eligible patients scheduled for screening will be identified through the health system and offered treatment, and outcomes like quit rates and program reach will be tracked over time. The study is designed to fit into routine care so successful approaches can be adopted by other health systems.
Who could benefit from this research
Good fit: People who currently smoke and are scheduled for lung cancer screening at one of the MedStar Health screening sites are ideal candidates.
Not a fit: People who do not smoke, who are not receiving lung screening at MedStar Health, or whose health prevents use of cessation treatments may not directly benefit from this project.
Why it matters
Potential benefit: If successful, this could help more people who smoke quit around the time of lung screening, reducing future lung cancer and saving lives.
How similar studies have performed: Previous studies show smoking-cessation treatments can help people quit and reduce lung cancer risk, but embedding and testing these approaches across large, diverse lung-screening programs is less common.
Where this research is happening
Washington, United States
- Georgetown University — Washington, United States (Active)
Researchers
- Principal investigator: Taylor, Kathryn L — Georgetown University
- Study coordinator: Taylor, Kathryn L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.